Unraveling morphology, methylation profiling, and diagnostic challenges in BRAF-Mutant pediatric glial and glioneuronal tumors

References

1. 1.↵
   1. Jaunmuktane Z,
   2. Capper D,
   3. Jones DTW,
   4. Schrimpf D,
   5. Sill M,
   6. Dut M, et al.

   Methylation Array Profiling of Adult Brain Tumours: Diagnostic Outcomes in a Large, Single Centre. Acta Neuropathol Commun 2019; 7: 24.

   OpenUrl
2. 2.
   1. Priesterbach-Ackley LP,
   2. Boldt HB,
   3. Petersen JK,
   4. Bervoets N,
   5. Scheie, D,
   6. Ulhøi BP, et al.

   Brain Tumour Diagnostics Using a DNA Methylation-Based Classifier as a Diagnostic Support Tool. Neuropathol Appl Neurobiol 2020; 46: 478-492.

   OpenUrlCrossRefPubMed
3. 3.↵
   1. Capper D,
   2. Stichel D,
   3. Sahm F,
   4. Jones DTW,
   5. Schrimpf D,
   6. Sill, M, et al.

   Practical Implementation of DNA Methylation and Copy-Number-Based CNS Tumor Diagnostics: The Heidelberg Experience. Acta Neuropathol 2018; 136: 181-210.

   OpenUrl
4. 4.↵
   1. Sturm D,
   2. Capper D,
   3. Andreiuolo F,
   4. Gessi M,
   5. Kölsche C,
   6. Reinhardt A, et al.

   Multiomic Neuropathology Improves Diagnostic Accuracy in Pediatric Neuro-Oncology. Nat Med 2023; 29: 917-926.

   OpenUrlCrossRef
5. 5.↵
   1. Schindler G,
   2. Capper D,
   3. Meyer J,
   4. Janzarik W,
   5. Omran H,
   6. Herold-Mende C, et al.

   Analysis of BRAF V600E Mutation in 1,320 Nervous System Tumors Reveals High Mutation Frequencies in Pleomorphic Xanthoastrocytoma, Ganglioglioma and Extra-Cerebellar Pilocytic Astrocytoma. Acta Neuropathol 2011; 121: 397-405.

   OpenUrlCrossRefPubMedWeb of Science
6. 6.↵
   1. Horbinski C,
   2. Nikiforova MN,
   3. Hagenkord JM,
   4. Hamilton RL,
   5. Pollack IF

   . Interplay among BRAF, p16, p53, and MIB1 in pediatric low-grade gliomas. Neuro Oncol 2012; 14: 777-789,

   OpenUrlCrossRefPubMed
7. 7.↵
   1. Perry A,
   2. Capper D,
   3. Ellison DW,
   4. Jones DTW,
   5. Reifenberger G

   . Diffuse Leptomeningeal Glioneuronal Tumour. In: WHO Classification of Tumours Editorial Board, editors. Central nervous system tumours; WHO classification of Tumours series. Lyon (France): International Agency for Research on Cancer; 2021.
8. 8.↵
   1. Alturkustani M

   . Diffuse GFAP Immunopositivity in the Oligodendrocyte-like Component of Pilocytic Astrocytoma Distinguishes It from Mimickers. Diagnostics (Basel) 2022; 12: 1632.

   OpenUrl
9. 9.↵
   1. Alturkustani M

   . Classification of Pediatric Gangliogliomas Based on the Histological Infiltration. Curr Oncol 2022; 29: 6764-6775.

   OpenUrl
10. 10.↵
    1. Reinhardt A,
    2. Pfister K,
    3. Schrimpf D,
    4. Stichel D,
    5. Sahm F,
    6. Reuss DE, et al.

    Anaplastic Ganglioglioma-A Diagnosis Comprising Several Distinct Tumour Types. Neuropathol Appl Neurobiol 2022; 48: e12847.

    OpenUrl
11. 11.↵
    1. Gupta K,
    2. Orisme W,
    3. Harreld JH,
    4. Qaddoumi I,
    5. Dalton JD,
    6. Punchihewa C, et al.

    Posterior Fossa and Spinal Gangliogliomas Form Two Distinct Clinicopathologic and Molecular Subgroups. Acta Neuropathol Commun 2014; 2: 18.

    OpenUrl
12. 12.↵
    1. Collins VP,
    2. Jones DTW,
    3. Giannini C

    . Pilocytic Astrocytoma: Pathology, Molecular Mechanisms and Markers. Neuropathol Appl Neurobiol 2022; 48: e12847.

    OpenUrl
13. 13.↵
    1. Capper D,
    2. Jones DTW,
    3. Sill M,
    4. Hovestadt V,
    5. Schrimpf D,
    6. Sturm D, et al.

    DNA Methylation-Based Classification of Central Nervous System Tumours. Nature 2018; 555: 469-474.

    OpenUrlCrossRefPubMed
14. 14.↵
    1. Alturkustani M

    . Diagnostic Insights into Pediatric Pleomorphic Xanthoastrocytoma through DNA Methylation Class and Pathological Diagnosis Analysis. Diagnostics (Basel) 2023; 13: 3464.

    OpenUrl
15. 15.↵
    1. Vaubel R,
    2. Zschernack V,
    3. Tran QT,
    4. Jenkins S,
    5. Caron A,
    6. Milosevic D, et al.

    Biology and Grading of Pleomorphic Xanthoastrocytoma-What Have We Learned about It? Brain Pathol 2021; 31: 20-32.

    OpenUrl
16. 16.↵
    1. Giannini C,
    2. Capper D,
    3. Figarella-Branger D,
    4. Jacques TS,
    5. Jones DTW,
    6. Louis DN, et al.

    In WHO Classification of Tumours Editorial Board. Central nervous system tumours.; WHO classification of Tumours series.; International Agency for Research on Cancer: Lyon (France), 2021; 6: 94–99.

    OpenUrl